EMAIL
Patient safety during general anesthesia depends on the precise delivery and continuous monitoring of inspired oxygen concentration. Both insufficient oxygen supply, which may lead to hypoxia, and excessive oxygen supply, which may contribute to oxygen toxicity, carry direct and serious consequences for anesthetized patients who are unable to self-regulate or signal distress.
In recognition of this risk, leading clinical and regulatory frameworks have established stringent requirements for oxygen monitoring in anesthetic workstations. The American Society of Anesthesiologists (ASA) Standards for Basic Anesthetic Monitoring, last amended in October 2025, state that during any general anesthetic administered using an anesthesia machine, an oxygen analyzer must be used to evaluate the concentration of oxygen in the breathing circuit, and the machine must be equipped with a functioning low oxygen concentration alarm. ISO 80601-2-13:2022, which defines the basic safety and essential performance requirements for anesthetic workstations, identifies oxygen concentration monitoring as a core measured parameter integral to the safe function of anesthetic delivery systems.
These requirements reflect the fundamental role of the oxygen sensor as a mandatory safety component within the anesthetic workstation, as its measurement accuracy directly determines the reliability of protective alarm functions throughout every procedure.
Anesthetic workstations present a particularly demanding operating environment for oxygen sensors. The breathing circuit carries a complex and continuously variable gas mixture that, in addition to oxygen and nitrogen, routinely includes nitrous oxide (N2O) and volatile halogenated anesthetic agents such as sevoflurane, desflurane, and isoflurane. The presence of these co-administered gases can introduce additional challenges for maintaining oxygen measurement accuracy within the anesthetic breathing circuit.
Sensor service life presents an additional operational challenge. Conventional electrochemical oxygen sensors used in anesthesia monitoring typically require replacement after approximately 18 to 24 months of operation to maintain measurement reliability and accuracy. In addition, the limited operational lifetime of oxygen sensors increases maintenance workload and long-term operational costs in high-utilization clinical environments such as operating rooms.
Together, these considerations highlight the importance of maintaining reliable oxygen monitoring performance throughout long-term clinical operation.
To meet the precision, reliability, and longevity requirements of oxygen monitoring in anesthetic workstations, Cubic, a leading manufacturer of gas sensors and gas analyzers, has developed Gasboard-2512, a compact oxygen sensor based on Tunable Diode Laser Absorption Spectroscopy (TDLAS) technology.
· High Gas Selectivity for Accurate Measurement in Mixed Anesthetic Gas Environments
Anesthetic breathing circuits contain a complex gas mixture that, in addition to oxygen and nitrogen, routinely includes nitrous oxide (N2O) and volatile halogenated anesthetic agents such as sevoflurane, desflurane, and isoflurane. Maintaining stable and accurate oxygen measurement performance under these mixed-gas conditions is therefore an important requirement for anesthetic workstation monitoring systems.
Gasboard-2512 utilizes TDLAS technology to measure oxygen concentration through laser absorption at a wavelength corresponding to a specific absorption line of the oxygen molecule. The high-selectivity optical measurement principle enables Gasboard-2512 to accurately quantify oxygen concentration within complex gas mixtures without cross-interference from background gases. With a resolution of 0.01% VOL and measurement accuracy of ± 1%FS + 2% reading, it is designed to support accurate oxygen concentration monitoring in anesthetic workstation applications.
When oxygen concentration in the breathing circuit falls outside the intended range, rapid sensor detection is critical to the timely activation of the workstation's low-oxygen alarm. With a response time less than 200 ms (@ 250 mL/min), Gasboard-2512 ensures that abnormal changes in oxygen concentration are detected promptly, supporting timely alarm activation and enabling healthcare professionals to respond in time.
Conventional electrochemical oxygen sensors used in anesthesia monitoring typically require replacement after approximately 18 to 24 months of operation to maintain measurement reliability. In high-utilization clinical environments such as operating rooms, the limited service life increases maintenance workload and long-term operational costs.
Gasboard-2512 adopts a non-consumptive TDLAS optical measurement principle designed for stable long-term oxygen monitoring performance. Unlike consumable electrochemical sensing elements, the laser-based sensing mechanism avoids the gradual depletion behavior associated with conventional electrochemical sensors during long-term operation. With a service lifetime of more than 10 years, Gasboard-2512 significantly reduces the replacement frequency in anesthetic workstation applications.
In addition, conventional electrochemical oxygen sensors used in anesthesia monitoring require daily calibration to maintain measurement accuracy. Frequent calibration procedures add to the operational workload of clinical and healthcare staff, particularly in high-utilization operating room environments. Gasboard-2512 does not require routine calibration procedures. The inherent stability of the TDLAS measurement principle ensures that sensor output remains consistent, eliminating the need for scheduled calibration interventions in clinical service and reducing the associated maintenance burden on device operators.
Beyond sensor measurement characteristics, system integration is also an important consideration for anesthetic workstation OEM design. Modern anesthetic workstations integrate multiple monitoring and gas delivery functions within limited internal installation space, placing greater demands on the size and integration flexibility of individual components, a consideration that directly affects system layout feasibility and integration complexity for OEM manufacturers developing anesthetic workstation platforms.
With a dimension of 45 × 31 × 30.5 mm, Gasboard-2512 is developed to accommodate the layout constraints of modern anesthetic workstation designs without compromising measurement performance. Gasboard-2512 supports UART digital communication for direct connection with the workstation's main control system, reducing interface complexity and supporting efficient integration into anesthetic workstation OEM development.
Gasboard-2512 is designed to serve as a reliable long-term oxygen sensing component for anesthetic workstation OEM integration, supporting accurate and stable oxygen monitoring throughout the operational lifecycle of the device.
Cubic brings more than two decades of focused development in gas sensing technology, with a technology portfolio spanning NDIR, TDLAS, and ultrasonic measurement platforms. Gasboard-2512 is built on this proprietary sensing foundation, with its measurement accuracy and operational reliability backed by years of deployment experience across medical and healthcare applications.
Core sensors and key components are manufactured in-house under controlled conditions, with optical assembly, calibration, and electronic integration carried out under strict quality standards to ensure product consistency and full traceability throughout the production process.
For anesthetic workstation manufacturers integrating oxygen sensing into their platforms, Cubic provides OEM and ODM partnership models supported by end-to-end development capabilities. Hardware design and software teams are available to adapt Gasboard-2512 to customer-defined interface requirements, installation constraints, and system communication protocols, while supply chain coordination ensures stable, scalable component availability across production cycles. From initial design-in support through to full-scale production, Cubic's engineering team engages directly with partners to ensure that integration requirements and regulatory traceability standards are met at every stage of the development process.
